<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou X</submitter><funding>American Liver Foundation</funding><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>National Natural Science Foundation of China</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>e70525</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12848849</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(3)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Immune-mediated bile duct injury is the primary histological feature of autoimmune cholestatic liver diseases. Macrophages, the most abundant immune cell population in the liver, have been postulated to play a critical role in biliary repair. However, it is unclear whether activated macrophages interact with injured biliary epithelial cells.&lt;h4>Methods&lt;/h4>We evaluated the expression of insulin-like growth factor-binding protein 4 (IGFBP4) in primary monocytes, MDMΦ, serum, and liver tissue sections from a total of 292 samples from PBC, PSC, and healthy controls using RNA-sequencing, ELISA, and immunohistochemistry analysis. The signal pathways involved in the effect of IGFBP4 in human intrahepatic biliary epithelial cells were examined by phospho-kinase arrays.</pubmed_abstract><journal>Liver international : official journal of the International Association for the Study of the Liver</journal><pubmed_title>IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury.</pubmed_title><pmcid>PMC12848849</pmcid><funding_grant_id>RO1 DK123262</funding_grant_id><funding_grant_id>82202000</funding_grant_id><funding_grant_id>2018</funding_grant_id><funding_grant_id>R01 DK123262</funding_grant_id><pubmed_authors>Leung PSC</pubmed_authors><pubmed_authors>Ansari AA</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Cheng Z</pubmed_authors><pubmed_authors>Ridgway WM</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Bowlus CL</pubmed_authors><pubmed_authors>Tanaka T</pubmed_authors><pubmed_authors>Invernizzi P</pubmed_authors><pubmed_authors>Tsuneyama K</pubmed_authors><pubmed_authors>Shao S</pubmed_authors><pubmed_authors>Gershwin ME</pubmed_authors></additional><is_claimable>false</is_claimable><name>IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury.</name><description>&lt;h4>Background and aims&lt;/h4>Immune-mediated bile duct injury is the primary histological feature of autoimmune cholestatic liver diseases. Macrophages, the most abundant immune cell population in the liver, have been postulated to play a critical role in biliary repair. However, it is unclear whether activated macrophages interact with injured biliary epithelial cells.&lt;h4>Methods&lt;/h4>We evaluated the expression of insulin-like growth factor-binding protein 4 (IGFBP4) in primary monocytes, MDMΦ, serum, and liver tissue sections from a total of 292 samples from PBC, PSC, and healthy controls using RNA-sequencing, ELISA, and immunohistochemistry analysis. The signal pathways involved in the effect of IGFBP4 in human intrahepatic biliary epithelial cells were examined by phospho-kinase arrays.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-06-09T05:44:13.302Z</modification><creation>2026-06-09T03:07:44.372Z</creation></dates><accession>S-EPMC12848849</accession><cross_references><pubmed>41603281</pubmed><doi>10.1111/liv.70525</doi></cross_references></HashMap>